Cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved properties as an anticancer agent
SE Alavi, S Muflih Al Harthi… - International Journal of …, 2019 - mdpi.com
This study aims to improve the cytotoxicity and potency of cisplatin-loaded
polybutylcyanoacrylate (PBCA) nanoparticles (NPs) for the treatment of lung cancer through …
polybutylcyanoacrylate (PBCA) nanoparticles (NPs) for the treatment of lung cancer through …
Investigating the properties and cytotoxicity of cisplatin-loaded nano-polybutylcyanoacrylate on breast cancer cells
A Gorgzadeh, A Hheidari, P Ghanbarikondori… - Asian Pacific Journal of …, 2023 - waocp.com
Background: This study aimed to develop a novel drug formulation using
polybutylcyanoacrylate (PBCA) nanoparticles to deliver cisplatin, a commonly used …
polybutylcyanoacrylate (PBCA) nanoparticles to deliver cisplatin, a commonly used …
Preparation, characterization, and evaluation of cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved in vitro and in vivo anticancer activities
This study aimed to evaluate the therapeutic efficacy of the cisplatin encapsulated into
polybutylcyanoacrylate (PBCA) nanoparticles for the treatment of kidney cancer. The …
polybutylcyanoacrylate (PBCA) nanoparticles for the treatment of kidney cancer. The …
Enhancing anti-cancer efficacy of carboplatin by PEGylated poly (butyl cyanoacrylate) nano-particles
M Hassanzadeganroudsari, A Heydarinasab… - Journal of Drug Delivery …, 2019 - Elsevier
Nano-drug delivery holds great potential to enhance the efficacy of carboplatin. This study
focused on cytotoxicity, in vitro drug release and characterization of poly (butyl …
focused on cytotoxicity, in vitro drug release and characterization of poly (butyl …
Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma
H Ebrahimi Shahmabadi, F Movahedi… - Tumor Biology, 2014 - Springer
Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …
Drug delivery of cisplatin to breast cancer by polybutylcyanoacrylate nanoparticles
M Koohi Moftakhari Esfahani, SE Alavi… - Advances in Polymer …, 2018 - Wiley Online Library
Breast cancer is the most common cancer and the second cause of cancer‐related death in
women worldwide. Chemotherapy of disease is impeded by subsequent relapse and …
women worldwide. Chemotherapy of disease is impeded by subsequent relapse and …
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles
Doxorubicin (Dox) is widely used for the combined chemotherapy of solid tumors. However,
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
the use of these drug associations in lung cancer has low antitumor efficacy. To improve its …
Preparation and physicochemical characterization of novel chlorambucil-loaded nanoparticles of poly (butylcyanoacrylate)
GG Yordanov, ZA Bedzhova, CD Dushkin - Colloid and Polymer Science, 2010 - Springer
The aim of the present study is the preparation and physicochemical characterization of
chlorambucil-loaded poly (butylcyanoacrylate) nanoparticles. Chlorambucil is a lipophilic …
chlorambucil-loaded poly (butylcyanoacrylate) nanoparticles. Chlorambucil is a lipophilic …
Engineering of hybrid anticancer drug-loaded polymeric nanoparticles delivery system for the treatment and care of lung cancer therapy
Y Zhao, K Liu, J Li, J Liao, L Ma - Drug Delivery, 2021 - Taylor & Francis
Chemotherapy with combination drugs has become one of the most commonly used cancer
prevention treatments, with positive clinical results. The goal of this study was to develop …
prevention treatments, with positive clinical results. The goal of this study was to develop …
Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment
Tumor eradication has many challenges due to the difficulty of selectively delivering
anticancer drugs to malignant cells avoiding contact with healthy tissues/organs. The …
anticancer drugs to malignant cells avoiding contact with healthy tissues/organs. The …
相关搜索
- butyl cyanoacrylate nano particles
- polybutylcyanoacrylate nanoparticles anticancer agent
- butyl cyanoacrylate pegylated poly
- pegylated poly nano particles
- polybutylcyanoacrylate nanoparticles breast cancer
- polybutylcyanoacrylate nanoparticles drug delivery
- polybutylcyanoacrylate nanoparticles anticancer activities